InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,346.99
(
-0.11%
)
US TECH 100
18,488.00
(
-0.25%
)
Dow Jones
38,798.99
(
-0.22%
)
Brent Oil
79.40
(
0.00%
)
Bitcoin
69,426.28
(
0.14%
)
Post# of 30990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

knuts4oe

Send PM Follow Ignore
Followers 4
Posts 682
Boards Moderated 0
Alias Born 06/26/2013

knuts4oe

Re: nep2134 post# 28120

Saturday, 04/15/2017 9:12:41 AM

Saturday, April 15, 2017 9:12:41 AM

Post# of 30990
Agree with you 110% that anatabine is (may be) much more than Alzheimer's. Even Dr Mullan has said repeatedly that Alzheimer's research is way too expensive and takes years for a proper study.

However, right now anatabine is NOTHING, ZERO, and has been totally ignored, like a crazy relative in the attic. If some success with Nilvadipine and AD can get some serious attention for anatabine, then I say hooray for Nilvad/A'bine.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up